nafamostat — Topline data
2026
All 12 clinical study sites now able to enroll patients to support an expected study completion in 2026Source filing
TLPH biotech catalysts & pipeline
TALPHERA INC · Data as of 2026-09-08
Upcoming catalysts
Niyad — Topline data
2026
The Niyad NEPHRO CRRT registrational trial is ongoing with completion expected in 2026.Source filing
Niyad — PDUFA
late 2026
Cash and investments at September 30, 2025 were $21.3 million; combined with conditional future tranches of previous financings, expect sufficient cash through a potential PMA approval of Niyad in late 2026Source filing